Stefan Knecht Selected Research

Stroke (Strokes)

1/2024	Effort-based decision making and motivational deficits in stroke patients.
1/2021	A decision-neuroscientific intervention to improve cognitive recovery after stroke.
1/2021	COVID-19 Reveals Opportunities for Better Care of Stroke Patients–Direct Transfer to Postacute Rehabilitation, Reduction in Length of Stay, and Treatment Outcomes.
3/2019	Quantitative Rapid Assessment of Leukoaraiosis in CT : Comparison to Gold Standard MRI.
1/2019	Second look Holter ECG in neurorehabilitation.
5/2016	Old benefit as much as young patients with stroke from high-intensity neurorehabilitation: cohort analysis.
1/2015	L-dopa does not add to the success of high-intensity language training in aphasia.
1/2011	Granulocyte-colony stimulating factor (G-CSF) in stroke patients with concomitant vascular disease--a randomized controlled trial.
10/2010	Integrity of the hippocampus and surrounding white matter is correlated with language training success in aphasia.
9/2009	Imaging short- and long-term training success in chronic aphasia.

For more, sign up at right for free...

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.

Realize the full power of the drug-disease research graph!

Stefan Knecht Research Topics

Disease

18	Stroke (Strokes) 01/2024 - 08/2004
8	Aphasia (Dysphasia) 01/2015 - 01/2004
2	Pain (Aches) 01/2021 - 04/2011
2	Ischemic Stroke 03/2019 - 01/2019
1	Hemorrhagic Stroke 01/2021
1	COVID-19 01/2021
1	Polyneuropathies (Polyneuropathy) 01/2021
1	Hemorrhage 03/2019
1	Anomia (Dysnomia) 07/2011
1	Headache (Headaches) 04/2011
1	Arthralgia (Joint Pain) 04/2011
1	Low Back Pain (Lumbago) 04/2011
1	Amyotrophic Lateral Sclerosis (Lou Gehrig's Disease) 03/2011
1	Vascular Diseases (Vascular Disease) 01/2011
1	Body Weight (Weight, Body) 01/2011
1	Memory Disorders (Memory Loss) 02/2009
1	Alzheimer Disease (Alzheimer's Disease) 02/2009
1	Weight Gain 12/2008
1	Obesity 12/2008
1	Hyperphagia (Overeating) 12/2008
1	Genetic Predisposition to Disease (Genetic Predisposition) 12/2008
1	Ischemia 09/2008
1	Paralysis (Palsy) 02/2006
1	Sepsis (Septicemia) 02/2006
1	Brain Diseases (Brain Disorder) 02/2006
1	Cortical Blindness (Anton Syndrome) 01/2003
1	Brain Injuries (Brain Injury) 01/2003

Drug/Important Bio-Agent (IBA)

5	Dopamine (Intropin)FDA LinkGeneric 02/2009 - 10/2006
4	Levodopa (L Dopa)FDA LinkGeneric 01/2015 - 11/2006
2	Granulocyte Colony-Stimulating Factor (G-CSF)IBA 03/2011 - 01/2011
2	Dextroamphetamine (Dexedrine)FDA LinkGeneric 10/2006 - 09/2004
1	Biomarkers (Surrogate Marker)IBA 03/2019
1	Carbidopa (Lodosyn)FDA LinkGeneric 01/2015
1	salicylhydroxamic acid (SHAM)IBA 07/2011
1	Pain-FreeIBA 04/2011

Therapy/Procedure

10	Therapeutics 01/2024 - 01/2003
6	Neurological Rehabilitation 01/2024 - 09/2008
5	Language Therapy (Language Training) 01/2015 - 01/2007
3	Transcranial Direct Current Stimulation 07/2011 - 08/2008
2	Anesthesia 09/2008 - 08/2004
1	Length of Stay 01/2021
1	Cognitive Training 01/2021
1	Activities of Daily Living (ADL) 01/2021
1	Aftercare (After-Treatment) 10/2010
1	Drug Therapy (Chemotherapy) 02/2006